Title: CAR T-Cell Therapy
Author: Steve Oh/Myriam Kirkman-Oh
Description: Chimeric Antigen Receptor (CAR) T Cell Therapy uses a viral vector to introduce DNA into a T Cell in order to engineer a specialized receptor/protein onto the surface of the T cell that recognized specific proteins on the surface of a tumor. The newly engineered cells need to be multiplied in the lab and reintroduced (infused) into the patient in order for them to help fight cancer in the patient.
Keywords: Color, Three-dimensional / Models, Advertising / Marketing, Editorial, Web, Professional Education, Allergy / Immunology, Biotechnology, Genetics